Condensed Consolidating Financial Information (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended			9 Months Ended
	Dec. 28, 2012		Dec. 30, 2011	Dec. 28, 2012		Dec. 30, 2011	Mar. 30, 2012
Assets, Current [Abstract]
Cash and cash equivalents	$ 216,134		$ 32,438	$ 216,134		$ 32,438
Accounts receivable, net	204,186			204,186			189,542
Inventories	177,482			177,482			147,198
Intercompany receivable (payable)	0			0			0
Prepaid expenses and other current assets	59,474			59,474			44,186
Assets held for sale	252,420	[1]		252,420	[1]		277,378	[1]
Total current assets	909,696			909,696			821,456
Property and equipment, net	82,420			82,420			80,151
Other Assets, Noncurrent [Abstract]
Goodwill	143,476			143,476			109,457
Intangibles, net	52,270			52,270			33,546
Investment in subsidiaries	0			0			0
Other assets	118,954			118,954			111,360
Total assets	1,306,816	[1]		1,306,816	[1]		1,155,970	[1]
Liabilities, Current [Abstract]
Accounts payable	147,379			147,379			118,719
Accrued expenses	55,892			55,892			37,436
Current portion of long-term debt	212,387			212,387			0
Other current liabilities	39,842			39,842			8,015
Liabilities held for sale	40,516	[1]		40,516	[1]		37,640	[1]
Total current liabilities	496,016			496,016			201,810
Revolving line of credit and long-term debt, excluding current portion	250,000			250,000			454,916
Other noncurrent liabilities	109,431			109,431			108,433
Total liabilities	855,447	[1]		855,447	[1]		765,159
Equity [Abstract]
Total PSS World Medical, Inc. shareholders' equity	448,274			448,274			387,128
Noncontrolling interest	3,095			3,095			3,683
Total equity	451,369			451,369			390,811
Total liabilities and equity	1,306,816			1,306,816			1,155,970
Unaudited Condensed Consolidated Statements of Operations [Abstract]
Net sales	433,912		394,203	1,264,099		1,166,404
Cost of goods sold	288,500		263,122	840,222		782,723
Gross profit	145,412		131,081	423,877		383,681
General and administrative expenses	83,858		70,436	241,810		210,046
Selling expenses	37,547		32,707	109,835		95,686
Equity earnings of subsidiaries	0		0	0		0
Income from operations	24,007		27,938	72,232		77,949
Other Income (Expense) [Abstract]
Interest expense	(8,778)		(4,784)	(25,820)		(13,864)
Interest Income	16		15	43		59
Other income, net	415		596	1,138		1,564
Other expense, net	(8,347)		(4,173)	(24,639)		(12,241)
(Loss) income from continuing operations before provision for income taxes	15,660		23,765	47,593		65,708
(Benefit) provision for income taxes	5,126		7,943	15,420		23,382
Income from continuing operations	10,534		15,822	32,173		42,326
Income from discontinued operations	28,113		4,307	32,404		12,075
Net income	38,647		20,129	64,577		54,401
Net loss attributable to noncontrolling interest	(73)		(3)	(157)		48
Net income attributable to PSS World Medical, Inc.	38,720		20,132	64,734		54,353
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net cash provided by operating activities				86,486		65,969
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments for business acquisitions, net of cash acquired				(73,558)		(16,794)
Capital expenditures				(16,462)		(15,622)
Cash proceeds from sale of discontinued operations, net				66,533		0
Other				(168)		(189)
Net cash used in investing activities, discontinued operations				(1,812)		(24,827)
Net cash used in investing activities				(25,467)		(57,432)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Purchase and retirement of common stock				(7,803)		(115,760)
Excess tax benefits from stock-based compensation arrangements				390		1,443
Payment for debt issuance costs				(685)		(1,835)
Proceeds from exercise of stock options				61		555
Proceeds from borrowings on the revolving line of credit				0		325,783
Repayments on the revolving line of credit				0		(209,533)
Payment of contingent consideration on business acquisitions				0		(4,000)
Payments under capital lease obligations				0		(547)
Intercompany dividend				0		0
Other				0		(1,523)
Net cash used in financing activities, discontinued operations				0		(30)
Net cash used in financing activities				(8,037)		(5,447)
Net (decrease) increase in cash and cash equivalents				52,982		3,090
Cash and cash equivalents, beginning of period				163,152		29,348
Cash and cash equivalents, end of period	216,134		32,438	216,134		32,438
Parent Company [Member]
Assets, Current [Abstract]
Cash and cash equivalents	150,045		2,417	150,045		2,417
Accounts receivable, net	137,502			137,502			137,214
Inventories	129,811			129,811			113,635
Intercompany receivable (payable)	367,765			367,765			290,404
Prepaid expenses and other current assets	54,227			54,227			39,483
Assets held for sale	0			0			26,975
Total current assets	839,350			839,350			725,159
Property and equipment, net	41,784			41,784			39,854
Other Assets, Noncurrent [Abstract]
Goodwill	34,824			34,824			31,319
Intangibles, net	10,242			10,242			10,435
Investment in subsidiaries	161,501			161,501			184,218
Other assets	102,075			102,075			95,951
Total assets	1,189,776			1,189,776			1,086,936
Liabilities, Current [Abstract]
Accounts payable	117,534			117,534			122,254
Accrued expenses	36,827			36,827			20,211
Current portion of long-term debt	212,387			212,387
Other current liabilities	29,268			29,268			2,667
Liabilities held for sale	0			0			4,025
Total current liabilities	396,016			396,016			149,157
Revolving line of credit and long-term debt, excluding current portion	250,000			250,000			454,916
Other noncurrent liabilities	92,392			92,392			92,052
Total liabilities	738,408			738,408			696,125
Equity [Abstract]
Total PSS World Medical, Inc. shareholders' equity	451,368			451,368			390,811
Noncontrolling interest	0			0			0
Total equity	451,368			451,368			390,811
Total liabilities and equity	1,189,776			1,189,776			1,086,936
Unaudited Condensed Consolidated Statements of Operations [Abstract]
Net sales	309,264		293,712	905,918		873,574
Cost of goods sold	216,844		208,739	638,060		622,570
Gross profit	92,420		84,973	267,858		251,004
General and administrative expenses	57,262		48,723	162,595		146,981
Selling expenses	27,815		25,219	81,526		74,186
Equity earnings of subsidiaries	9,947		6,674	26,399		17,868
Income from operations	17,290		17,705	50,136		47,705
Other Income (Expense) [Abstract]
Interest expense	(8,770)		(4,723)	(25,794)		(13,530)
Interest Income	364		359	1,069		1,026
Other income, net	249		435	627		1,043
Other expense, net	(8,157)		(3,929)	(24,098)		(11,461)
(Loss) income from continuing operations before provision for income taxes	9,133		13,776	26,038		36,244
(Benefit) provision for income taxes	(8,629)		(5,170)	(25,328)		(14,886)
Income from continuing operations	17,762		18,946	51,366		51,130
Income from discontinued operations	26,297		1,179	28,604		3,256
Net income	44,059		20,125	79,970		54,386
Net loss attributable to noncontrolling interest	0		0	0		0
Net income attributable to PSS World Medical, Inc.	44,059		20,125	79,970		54,386
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net cash provided by operating activities				(46,835)		(36,856)
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments for business acquisitions, net of cash acquired				(5,620)		(524)
Capital expenditures				(6,373)		(2,224)
Cash proceeds from sale of discontinued operations, net				66,533
Other				7		(189)
Net cash used in investing activities, discontinued operations				(300)		(22)
Net cash used in investing activities				54,247		(2,959)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Purchase and retirement of common stock				(7,803)		(115,760)
Excess tax benefits from stock-based compensation arrangements				390		1,443
Payment for debt issuance costs				(685)		(1,835)
Proceeds from exercise of stock options				61		555
Proceeds from borrowings on the revolving line of credit						325,783
Repayments on the revolving line of credit						(209,533)
Payment of contingent consideration on business acquisitions						0
Payments under capital lease obligations						(33)
Intercompany dividend				33,222		29,234
Other						(1,523)
Net cash used in financing activities, discontinued operations				0		0
Net cash used in financing activities				25,185		28,331
Net (decrease) increase in cash and cash equivalents				32,597		(11,484)
Cash and cash equivalents, beginning of period				117,448		13,901
Cash and cash equivalents, end of period	150,045		2,417	150,045		2,417
Guarantor Subsidiaries [Member]
Assets, Current [Abstract]
Cash and cash equivalents	25,217		15,251	25,217		15,251
Accounts receivable, net	66,684			66,684			22,591
Inventories	47,465			47,465			33,310
Intercompany receivable (payable)	(352,030)			(352,030)			(253,925)
Prepaid expenses and other current assets	4,905			4,905			4,590
Assets held for sale	252,986			252,986			250,522
Total current assets	45,227			45,227			70,617
Property and equipment, net	40,564			40,564			40,189
Other Assets, Noncurrent [Abstract]
Goodwill	108,652			108,652			78,138
Intangibles, net	42,028			42,028			23,111
Investment in subsidiaries	37,719			37,719			23,942
Other assets	16,844			16,844			15,373
Total assets	291,034			291,034			251,370
Liabilities, Current [Abstract]
Accounts payable	29,257			29,257			(4,121)
Accrued expenses	19,024			19,024			17,176
Current portion of long-term debt	0			0
Other current liabilities	10,652			10,652			5,348
Liabilities held for sale	41,956			41,956			36,456
Total current liabilities	100,889			100,889			54,859
Revolving line of credit and long-term debt, excluding current portion	0			0			0
Other noncurrent liabilities	17,039			17,039			16,381
Total liabilities	117,928			117,928			71,240
Equity [Abstract]
Total PSS World Medical, Inc. shareholders' equity	173,106			173,106			179,536
Noncontrolling interest	0			0			594
Total equity	173,106			173,106			180,130
Total liabilities and equity	291,034			291,034			251,370
Unaudited Condensed Consolidated Statements of Operations [Abstract]
Net sales	122,903		98,046	343,483		284,024
Cost of goods sold	70,265		53,043	188,980		157,581
Gross profit	52,638		45,003	154,503		126,443
General and administrative expenses	25,468		20,815	75,813		60,260
Selling expenses	9,732		7,488	28,309		21,500
Equity earnings of subsidiaries	4,689		243	13,551		3,591
Income from operations	22,127		16,943	63,932		48,274
Other Income (Expense) [Abstract]
Interest expense	(8)		(61)	(26)		(334)
Interest Income	(348)		(344)	(1,027)		(967)
Other income, net	167		161	514		533
Other expense, net	(189)		(244)	(539)		(768)
(Loss) income from continuing operations before provision for income taxes	21,938		16,699	63,393		47,506
(Benefit) provision for income taxes	13,755		13,113	40,748		38,268
Income from continuing operations	8,183		3,586	22,645		9,238
Income from discontinued operations	1,764		3,087	3,754		8,630
Net income	9,947		6,673	26,399		17,868
Net loss attributable to noncontrolling interest	(120)		33	(164)		90
Net income attributable to PSS World Medical, Inc.	10,067		6,640	26,563		17,778
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net cash provided by operating activities				124,125		99,912
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments for business acquisitions, net of cash acquired				(67,438)		(16,270)
Capital expenditures				(10,088)		(13,393)
Cash proceeds from sale of discontinued operations, net				0
Other				(175)		0
Net cash used in investing activities, discontinued operations				(1,513)		(24,788)
Net cash used in investing activities				(79,214)		(54,451)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Purchase and retirement of common stock				0		0
Excess tax benefits from stock-based compensation arrangements				0		0
Payment for debt issuance costs				0		0
Proceeds from exercise of stock options				0		0
Proceeds from borrowings on the revolving line of credit						0
Repayments on the revolving line of credit						0
Payment of contingent consideration on business acquisitions						(4,000)
Payments under capital lease obligations						(514)
Intercompany dividend				(33,223)		(29,234)
Other						0
Net cash used in financing activities, discontinued operations				0		(30)
Net cash used in financing activities				(33,223)		(33,778)
Net (decrease) increase in cash and cash equivalents				11,688		11,683
Cash and cash equivalents, beginning of period				13,529		3,568
Cash and cash equivalents, end of period	25,217		15,251	25,217		15,251
Non-Guarantor Subsidiaries [Member]
Assets, Current [Abstract]
Cash and cash equivalents	40,872		14,770	40,872		14,770
Accounts receivable, net	0			0			29,737
Inventories	206			206			253
Intercompany receivable (payable)	(2,355)			(2,355)			(37,043)
Prepaid expenses and other current assets	342			342			113
Assets held for sale	2,183			2,183			2,526
Total current assets	41,248			41,248			27,761
Property and equipment, net	72			72			108
Other Assets, Noncurrent [Abstract]
Goodwill	0			0			0
Intangibles, net	0			0			0
Investment in subsidiaries	0			0			0
Other assets	35			35			36
Total assets	41,355			41,355			27,905
Liabilities, Current [Abstract]
Accounts payable	588			588			586
Accrued expenses	41			41			49
Current portion of long-term debt	0			0
Other current liabilities	(78)			(78)			0
Liabilities held for sale	3,152			3,152			3,095
Total current liabilities	3,703			3,703			3,730
Revolving line of credit and long-term debt, excluding current portion	0			0			0
Other noncurrent liabilities	0			0			0
Total liabilities	3,703			3,703			3,730
Equity [Abstract]
Total PSS World Medical, Inc. shareholders' equity	37,652			37,652			24,175
Noncontrolling interest	0			0			0
Total equity	37,652			37,652			24,175
Total liabilities and equity	41,355			41,355			27,905
Unaudited Condensed Consolidated Statements of Operations [Abstract]
Net sales	27,295		2,445	80,770		8,806
Cost of goods sold	21,524		1,340	63,846		2,572
Gross profit	5,771		1,105	16,924		6,234
General and administrative expenses	1,128		898	3,402		2,805
Selling expenses	0		0	0		0
Equity earnings of subsidiaries	0		0	0		0
Income from operations	4,643		207	13,522		3,429
Other Income (Expense) [Abstract]
Interest expense	0		0	0		0
Interest Income	0		0	1		0
Other income, net	(1)		0	(3)		(12)
Other expense, net	(1)		0	(2)		(12)
(Loss) income from continuing operations before provision for income taxes	4,642		207	13,520		3,417
(Benefit) provision for income taxes	0		0	0		0
Income from continuing operations	4,642		207	13,520		3,417
Income from discontinued operations	47		36	31		174
Net income	4,689		243	13,551		3,591
Net loss attributable to noncontrolling interest	0		0	0		0
Net income attributable to PSS World Medical, Inc.	4,689		243	13,551		3,591
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net cash provided by operating activities				9,118		2,913
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments for business acquisitions, net of cash acquired				(500)		0
Capital expenditures				(1)		(5)
Cash proceeds from sale of discontinued operations, net				0
Other				0		0
Net cash used in investing activities, discontinued operations				1		(17)
Net cash used in investing activities				(500)		(22)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Purchase and retirement of common stock				0		0
Excess tax benefits from stock-based compensation arrangements				0		0
Payment for debt issuance costs				0		0
Proceeds from exercise of stock options				0		0
Proceeds from borrowings on the revolving line of credit						0
Repayments on the revolving line of credit						0
Payment of contingent consideration on business acquisitions						0
Payments under capital lease obligations						0
Intercompany dividend				1		0
Other						0
Net cash used in financing activities, discontinued operations				78		0
Net cash used in financing activities				79		0
Net (decrease) increase in cash and cash equivalents				8,697		2,891
Cash and cash equivalents, beginning of period				32,175		11,879
Cash and cash equivalents, end of period	40,872		14,770	40,872		14,770
Consolidation, Eliminations [Member]
Assets, Current [Abstract]
Cash and cash equivalents	0		0	0		0
Accounts receivable, net	0			0			0
Inventories	0			0			0
Intercompany receivable (payable)	(13,380)			(13,380)			564
Prepaid expenses and other current assets	0			0			0
Assets held for sale	(2,749)			(2,749)			(2,645)
Total current assets	(16,129)			(16,129)			(2,081)
Property and equipment, net	0			0			0
Other Assets, Noncurrent [Abstract]
Goodwill	0			0			0
Intangibles, net	0			0			0
Investment in subsidiaries	(199,220)			(199,220)			(208,160)
Other assets	0			0			0
Total assets	(215,349)			(215,349)			(210,241)
Liabilities, Current [Abstract]
Accounts payable	0			0			0
Accrued expenses	0			0			0
Current portion of long-term debt	0			0
Other current liabilities	0			0			0
Liabilities held for sale	(4,592)			(4,592)			(5,936)
Total current liabilities	(4,592)			(4,592)			(5,936)
Revolving line of credit and long-term debt, excluding current portion	0			0			0
Other noncurrent liabilities	0			0			0
Total liabilities	(4,592)			(4,592)			(5,936)
Equity [Abstract]
Total PSS World Medical, Inc. shareholders' equity	(213,852)			(213,852)			(207,394)
Noncontrolling interest	3,095			3,095			3,089
Total equity	(210,757)			(210,757)			(204,305)
Total liabilities and equity	(215,349)			(215,349)			(210,241)
Unaudited Condensed Consolidated Statements of Operations [Abstract]
Net sales	(25,550)		0	(66,072)		0
Cost of goods sold	(20,133)		0	(50,664)		0
Gross profit	(5,417)		0	(15,408)		0
General and administrative expenses	0		0	0		0
Selling expenses	0		0	0		0
Equity earnings of subsidiaries	(14,636)		(6,917)	(39,950)		(21,459)
Income from operations	(20,053)		(6,917)	(55,358)		(21,459)
Other Income (Expense) [Abstract]
Interest expense	0		0	0		0
Interest Income	0		0	0		0
Other income, net	0		0	0		0
Other expense, net	0		0	0		0
(Loss) income from continuing operations before provision for income taxes	(20,053)		(6,917)	(55,358)		(21,459)
(Benefit) provision for income taxes	0		0	0		0
Income from continuing operations	(20,053)		(6,917)	(55,358)		(21,459)
Income from discontinued operations	5		5	15		15
Net income	(20,048)		(6,912)	(55,343)		(21,444)
Net loss attributable to noncontrolling interest	47		(36)	7		(42)
Net income attributable to PSS World Medical, Inc.	(20,095)		(6,876)	(55,350)		(21,402)
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net cash provided by operating activities				78		0
Net Cash Provided by (Used in) Investing Activities [Abstract]
Payments for business acquisitions, net of cash acquired				0		0
Capital expenditures				0		0
Cash proceeds from sale of discontinued operations, net				0
Other				0		0
Net cash used in investing activities, discontinued operations				0		0
Net cash used in investing activities				0		0
Net Cash Provided by (Used in) Financing Activities [Abstract]
Purchase and retirement of common stock				0		0
Excess tax benefits from stock-based compensation arrangements				0		0
Payment for debt issuance costs				0		0
Proceeds from exercise of stock options				0		0
Proceeds from borrowings on the revolving line of credit						0
Repayments on the revolving line of credit						0
Payment of contingent consideration on business acquisitions						0
Payments under capital lease obligations						0
Intercompany dividend				0		0
Other						0
Net cash used in financing activities, discontinued operations				(78)		0
Net cash used in financing activities				(78)		0
Net (decrease) increase in cash and cash equivalents				0		0
Cash and cash equivalents, beginning of period				0		0
Cash and cash equivalents, end of period	$ 0		$ 0	$ 0		$ 0

[1] See Footnote 3, Discontinued Operations and Plan of Merger, for discussion of assets and liabilities held for sale. See Footnote 4, Variable Interest Entity, for discussion of the assets and liabilities related to the Company’s consolidated variable interest entities.